What is Alzheimer's disease?

Alzheimer's disease (AD) is a progressive neurodegenerative pathology that is the leading cause of dementia in the elderly. It is characterized by the degeneration and functional loss of brain cells, which gradually deteriorates cognitive functions, memory, thinking abilities and behavior. According to the World Health Organization (WHO), Alzheimer's disease affects approximately 50 million people worldwide, and this number continues to rise due to an aging population.

The pathogenesis of Alzheimer's disease is closely related to the formation of amyloid plaques and neurofibrillary tangles in the brain, which cause neuronal damage and brain atrophy. These pathological processes begin many years before the onset of clinical symptoms, making early diagnosis and development of interventions an essential research goal. Although the exact cause of the disease is still not fully understood, several factors, including genetic, environmental and lifestyle factors, have been recognized as possible contributors.

Symptoms and signs

Early stage symptoms

Early symptoms of Alzheimer's disease are often subtle and can be mistaken for normal aging. Initially, patients may experience short-term memory impairment, manifested as forgetting recent events or conversations. Observed difficulty concentrating and performing more complex tasks. Some patients may also develop mild language problems, such as difficulty finding the right words. These symptoms may manifest as mild confusion or unexpected errors in normal activities.

Symptoms of an advanced stage

As Alzheimer's disease progresses, symptoms become more pronounced and more severe. Patients may lose the ability to recognize familiar people and places and experience disorientation in time and space. Difficulty with daily activities such as cooking, shopping and managing finances. Behavioral changes such as irritability, depression and social withdrawal are becoming more common. Hallucinations, illusions and personality changes may also develop in the late stages of the disease. These symptoms significantly affect the quality of life of the patient and their family members.

Disease causes and risk factors

Genetic factors

Genetics play a major role in the development of Alzheimer's disease, especially in its rare, early-onset form, which begins before age 65. Genes such as APP, PSEN1, and PSEN2 are associated with this early-onset form and are transmitted in an autosomal dominant manner. Later-onset Alzheimer's disease also has a genetic component, with the APOE ε4 gene being important. Individuals with one or two APOE ε4 alleles have an increased risk of the disease, although the presence of the gene is not determinative. Genetic predisposition is only part of the overall complex of risk factors, and genetic testing can be important, especially in the early stages of the disease.

Environmental and lifestyle factors

In addition to genetic factors, environmental and lifestyle factors can significantly influence the development of Alzheimer's disease. Chronic health problems such as hypertension, diabetes and hypercholesterolemia are associated with an increased risk. Likewise, a low level of physical activity, unhealthy diet and smoking can contribute to the development of the disease. Recent studies point to the influence of psychosocial factors such as educational level and social activity on cognitive reserve and dementia risk. Lifestyle changes that promote a healthy cardiovascular system may be helpful in reducing the risk of Alzheimer's disease.

Diagnostic process

Medical history and physical examination

Diagnosing Alzheimer's disease begins with a thorough medical history and physical examination. Doctors evaluate a patient's cognitive function using a variety of neuropsychological tests that measure memory, language, problem solving, and other cognitive skills. A history is also taken from family members or caregivers to get a more complete picture of the onset and progression of symptoms. This information is essential to develop a personalized treatment plan.

Imaging and laboratory tests

Imaging tests such as magnetic resonance imaging (MRI) or computed tomography (CT) are performed to confirm the diagnosis of Alzheimer's disease and rule out other causes of cognitive impairment. These tests help detect structural changes in the brain, such as atrophy. Positron emission tomography (PET) scans are sometimes used to assess the presence of amyloid and tau proteins in the brain. Blood and cerebrospinal fluid tests can help assess levels of biomarkers associated with Alzheimer's disease. Genetic tests are sometimes used to assess the presence of genetic biomarkers that could help more accurately determine disease risk and prognosis.

Treatment options

Holistic approach

Lifestyle changes and care

Domestic adjustments

It is important to make daily life adjustments to improve the quality of life of patients and their family members. These adaptations may include safety measures such as placing items in easily accessible areas to reduce the risk of falls and the use of technology such as reminders. Maintaining a structured daily routine is essential for Alzheimer's patients, as it can help reduce confusion and anxiety. Home security is an important consideration and technology such as GPS tracking devices is recommended to prevent the risk of getting lost. Domestic adaptations also include simple visual markings and improved lighting to help navigate the home.

Support for patients and families

Alzheimer's disease has a significant impact not only on patients, but also on family members and caregivers. It is therefore important to provide emotional and practical support. Support groups and counseling can help families cope with the emotional challenges of the disease's progression. Available resources, such as day centers and professional home care, can offer needed respite for caregivers and provide a safe environment for patients. It is important to inform families about available support resources and options. Educational seminars and training programs can help caregivers better understand the disease and develop skills for effective caregiving.

Research and recent findings

New treatment approaches

Prevention strategies

In addition to developing treatments, researchers are focusing on prevention strategies for Alzheimer's disease. Various lifestyle factors, such as diet, physical activity and cognitive activity, are being studied to see how they might affect disease risk. There is evidence that a Mediterranean diet rich in fruits, vegetables and omega-3 fatty acids can reduce the risk of dementia. In addition, the effects of various vitamins and minerals, such as B vitamins and vitamin D, on cognitive health are also being studied. Regular physical activity and cognitively stimulating activities, such as solving puzzles or learning new skills, can increase cognitive reserve and reduce the risk of dementia. Social interaction and active involvement in community life is also recognized as an important factor that can help maintain mental health.

Conclusions

Summary and recommendations

Further research into the mechanisms of Alzheimer's disease and the development of new treatment approaches is essential to develop more effective strategies for the management and prevention of the disease. Until then, healthy lifestyles and early medical intervention remain the best approach to reduce the impact of the disease on patients and society at large. It is important to continue to develop caregiver support programs and provide resources to help families overcome these challenges. Through public education and awareness of Alzheimer's disease, early diagnosis can be promoted and innovative solutions that promote the well-being of patients and their families can be supported.